In human colon cancer HT-29 and LoVo cells, genistein could stimulate apoptosis by downregulating the NF-κB pathway and Bcl-2 while upregulating Bax; therefore, it provides the basis for genistein clinical application in colon cancer cases [141]. This evidence concerns the gene NFKB1 and colonic neoplasm.